Stock chart
Ticker: EVLO Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-11-08 2023-11-08 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
3,103 -15.4%
0.33
USD 1,024
3,103 -15.4% 0.33 USD 1,024
2023-11-08 2023-11-08 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
3,163 -10.9%
0.33
USD 1,044
3,163 -10.9% 0.33 USD 1,044
2023-11-08 2023-11-08 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
1,811 -7.5%
0.33
USD 598
1,811 -7.5% 0.33 USD 598
2023-11-08 2023-11-08 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
172 -1.0%
0.33
USD 57
172 -1.0% 0.33 USD 57
2023-11-03 2023-11-02 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
3,999 -18.5%
0.33
USD 1,320
3,999 -18.5% 0.33 USD 1,320
2023-11-03 2023-11-02 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
6,854 -23.5%
0.33
USD 2,262
6,854 -23.5% 0.33 USD 2,262
2023-11-03 2023-11-02 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
6,854 -33.5%
0.33
USD 2,262
6,854 -33.5% 0.33 USD 2,262
2023-09-29 2023-09-28 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
1,996 -10.6%
3.94
USD 7,864
1,996 -10.6% 3.94 USD 7,864
2023-08-09 2023-08-08 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
2,004 -18.1%
9.51
USD 19,058
2,004 -18.1% 9.51 USD 19,058
2023-08-09 2023-08-08 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
342 -8.3%
9.51
USD 3,252
342 -8.3% 9.51 USD 3,252
2023-08-09 2023-08-08 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
3,128 -15.8%
9.51
USD 29,747
3,128 -15.8% 9.51 USD 29,747
2023-08-09 2023-08-08 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
3,434 -30.2%
9.51
USD 32,657
3,434 -30.2% 9.51 USD 32,657
2023-07-13 2023-07-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
3,246,753 +474.0%
2.31
USD 7,499,999
3,246,753 +474.0% 2.31 USD 7,499,999
2023-07-13 2023-07-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,082,251 +263.3%
2.31
USD 2,500,000
1,082,251 +263.3% 2.31 USD 2,500,000
2023-07-13 2023-07-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,082,251 +285.1%
2.31
USD 2,500,000
1,082,251 +285.1% 2.31 USD 2,500,000
2023-06-12 2023-05-23 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
22,571 -7.9%
0.14
USD 3,201
22,571 -7.9% 0.14 USD 3,201
2023-05-10 2023-05-08 PS Planned sale

Thorell Marella

Chief Financial Officer

Officer
38,531 -29.6%
0.13
USD 4,836
38,531 -29.6% 0.13 USD 4,836
2023-05-10 2023-05-08 PS Planned sale

Bodmer Mark

CSO, President of R&D

Officer
68,014 -19.3%
0.13
USD 8,536
68,014 -19.3% 0.13 USD 8,536
2023-05-10 2023-05-08 PS Planned sale

GILL SIMBA

President & CEO

Executive Director
3,537 -5.7%
0.13
USD 444
3,537 -5.7% 0.13 USD 444
2023-05-10 2023-05-08 PS Planned sale

McHale Duncan

Chief Medical Officer

Officer
66,730 -40.6%
0.13
USD 8,375
66,730 -40.6% 0.13 USD 8,375
2023-01-23 2023-01-23 S Sale

CARRIERE STEPHEN J

Principal Accounting Officer

Officer
151 -42.7%
1.06
USD 160
151 -42.7% 1.06 USD 160
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
13,698,630 +inf%
1.46
USD 20,000,000
13,698,630 +inf% 1.46 USD 20,000,000
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
6,849,315 +499.8%
1.46
USD 10,000,000
6,849,315 +499.8% 1.46 USD 10,000,000
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,369,863 +33.2%
1.46
USD 2,000,000
1,369,863 +33.2% 1.46 USD 2,000,000
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,095,890 +138.5%
1.46
USD 1,599,999
1,095,890 +138.5% 1.46 USD 1,599,999
2022-06-01 2022-05-27 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
4,383,561 +136.7%
1.46
USD 6,399,999
4,383,561 +136.7% 1.46 USD 6,399,999
2022-05-31 2022-05-27 B Purchase

Darzi Lord Ara

Non-Executive Director
342,465 +inf%
1.46
USD 499,999
342,465 +inf% 1.46 USD 499,999
2022-05-31 2022-05-27 B Purchase

McHale Duncan

Chief Medical Officer

Officer
34,246 +inf%
1.46
USD 49,999
34,246 +inf% 1.46 USD 49,999
2022-05-31 2022-05-27 B Purchase

Epstein David R

Non-Executive Director
17,123 +25.6%
1.46
USD 25,000
17,123 +25.6% 1.46 USD 25,000
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
46,429 +1.1%
15.00
USD 696,435
46,429 +1.1% 15.00 USD 696,435
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
37,143 +2.8%
15.00
USD 557,145
37,143 +2.8% 15.00 USD 557,145
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
9,285 +1.2%
15.00
USD 139,275
9,285 +1.2% 15.00 USD 139,275
2021-02-04 2021-02-02 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
37,143 +1.2%
15.00
USD 557,145
37,143 +1.2% 15.00 USD 557,145
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
200 +1.1%
7.02
USD 1,404
200 +1.1% 7.02 USD 1,404
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
500 +2.9%
6.98
USD 3,490
500 +2.9% 6.98 USD 3,490
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
1,000 +6.2%
6.91
USD 6,910
1,000 +6.2% 6.91 USD 6,910
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
800 +5.3%
7.16
USD 5,728
800 +5.3% 7.16 USD 5,728
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
4,970 +48.6%
6.49
USD 32,255
4,970 +48.6% 6.49 USD 32,255
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
30 +0.3%
6.45
USD 194
30 +0.3% 6.45 USD 194
2020-12-14 2020-12-11 B Purchase

Epstein David R

Non-Executive Director
200 +2.0%
6.40
USD 1,280
200 +2.0% 6.40 USD 1,280
2020-12-02 2020-12-01 S Sale

Liu Xiaoli Jacqueline

Principal Accounting Officer

Officer
3,000 -100.0%
5.17
USD 15,510
3,000 -100.0% 5.17 USD 15,510
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
1,000 +11.1%
4.58
USD 4,580
1,000 +11.1% 4.58 USD 4,580
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
1,000 +12.5%
4.48
USD 4,480
1,000 +12.5% 4.48 USD 4,480
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
1,000 +14.3%
4.47
USD 4,470
1,000 +14.3% 4.47 USD 4,470
2020-09-01 2020-08-31 B Purchase

Epstein David R

Non-Executive Director
2,752 +64.8%
4.46
USD 12,274
2,752 +64.8% 4.46 USD 12,274
2020-09-01 2020-08-28 B Purchase

Epstein David R

Non-Executive Director
3,248 +324.8%
4.40
USD 14,291
3,248 +324.8% 4.40 USD 14,291
2020-09-01 2020-08-28 B Purchase

Epstein David R

Non-Executive Director
1,000 +inf%
4.34
USD 4,340
1,000 +inf% 4.34 USD 4,340
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,666,667 +69.1%
3.75
USD 6,250,001
1,666,667 +69.1% 3.75 USD 6,250,001
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,333,333 +inf%
3.75
USD 4,999,999
1,333,333 +inf% 3.75 USD 4,999,999
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
333,333 +74.3%
3.75
USD 1,249,999
333,333 +74.3% 3.75 USD 1,249,999
2020-07-01 2020-06-29 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
1,333,333 +72.6%
3.75
USD 4,999,999
1,333,333 +72.6% 3.75 USD 4,999,999
2018-05-15 2018-05-11 B Purchase

Flagship Ventures Fund IV General Partner LLC

Large shareholder
281,250 +1.6%
16.00
USD 4,500,000
281,250 +1.6% 16.00 USD 4,500,000
2018-05-15 2018-05-11 B Purchase

Flagship Ventures Fund V General Partner LLC

Large shareholder
281,250 +1.6%
16.00
USD 4,500,000
281,250 +1.6% 16.00 USD 4,500,000
// ... existing code ... // ... rest of the file ...